#VisualAbstract: Sentinel-node biopsy only is noninferior to

#VisualAbstract: Sentinel-node biopsy only is noninferior to completion of axillary lymph node dissection in breast cancer with sentinel-node metastases

1. The hazard ratio for recurrence or death comparing sentinel node biopsy only to completion axillary lymph node dissection was non-significant (0.89) and below the noninferiority margin. 2. The overall survival rates at 5 years were similar between both groups, 92.9% vs 92%. Evidence Rating Level: 1 (Excellent) Study Rundown: Previous studies have challenged the necessity

Related Keywords

, Minute Medicine Inc , Rating Level , Axillary Dissection , Sentinel Node , Lymph Node Metastasis , Axillary Lymph Node Dissection , Breast Cancer , Cancer , Completion Axillary Lymph Node Dissection , Lymph Node , Sentinel Lymph Node Biopsy , Studygraphics ,

© 2024 Vimarsana
#VisualAbstract: Sentinel-node Biopsy Only Is Noninferior To Completion Of Axillary Lymph Node Dissection In Breast Cancer With Sentinel-node Metastases : Comparemela.com

#VisualAbstract: Sentinel-node biopsy only is noninferior to completion of axillary lymph node dissection in breast cancer with sentinel-node metastases

Card image cap

1. The hazard ratio for recurrence or death comparing sentinel node biopsy only to completion axillary lymph node dissection was non-significant (0.89) and below the noninferiority margin. 2. The overall survival rates at 5 years were similar between both groups, 92.9% vs 92%. Evidence Rating Level: 1 (Excellent) Study Rundown: Previous studies have challenged the necessity

Related Keywords

, Minute Medicine Inc , Rating Level , Axillary Dissection , Sentinel Node , Lymph Node Metastasis , Axillary Lymph Node Dissection , Breast Cancer , Cancer , Completion Axillary Lymph Node Dissection , Lymph Node , Sentinel Lymph Node Biopsy , Studygraphics ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.